Panelist, "Non-Delaware Law Corporate Governance Issues in M&A and Related Transactions," 9th Annual Institute Corporate, Securities, and Related Aspects of Mergers and Acquisitions
This event has already occurred.
Related Insights
Amgen Files Three New Prolia® / Xgeva® BPCIA Litigations Against Hikma, Shanghai Henlius Biotech, and Biocon’s Proposed Biosimilars